Skip to Main Content

Browse issues

The Journal of Infectious Diseases Cover Image for Volume 221, Issue 1
Volume 221, Issue 1
1 January 2020
ISSN 0022-1899
EISSN 1537-6613

Volume 221, Issue 1, 1 January 2020

EDITORIAL COMMENTARIES

Robert L Atmar and Wendy A Keitel
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Pages 1–4, https://doi.org/10.1093/infdis/jiz545
Cheryl Cohen and Marta C Nunes
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Pages 5–7, https://doi.org/10.1093/infdis/jiz387

MAJOR ARTICLES AND BRIEF REPORTS

INFLUENZA VACCINES

Brendan Flannery and others
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Pages 8–15, https://doi.org/10.1093/infdis/jiz543

During the 2018–2019 season in the US, influenza vaccination provided protection against illness due to influenza A(H1N1)pdm09 virus but was not effective against the major clade of A(H3N2) viruses that differed antigenically from the A(H3N2) vaccine component.

Jemma L Walker and others
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Pages 16–20, https://doi.org/10.1093/infdis/jiz310

We show that maternal influenza vaccination provides significant protection for infants in the first 6 months of life against influenza-related hospitalization in both the A(H1N1)pdm09– and A(H3N2)–dominated seasons.

Sarah Lartey and others
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Pages 21–32, https://doi.org/10.1093/infdis/jiz321

Live attenuated influenza vaccine induces rapid influenza-specific tonsillar TFH-cell and antibody responses in children, but is less potent in adults. The magnitude of influenza-specific TFH-cell responses inversely correlated with pre-existing salivary IgA, and directly associated with post-vaccination antibody fold-induction.

Tiffany W Y Ng and others
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Pages 33–41, https://doi.org/10.1093/infdis/jiz327

We identified reduced immune responses to vaccination among older adults with repeated annual influenza vaccination, and we found that the reduction was more pronounced when vaccine components in the prior and current vaccines were identical.

Andrea S Gershon and others
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Pages 42–52, https://doi.org/10.1093/infdis/jiz419

Influenza vaccination is modestly effective in reducing laboratoryconfirmed influenza-associated hospitalizations in people with COPD.

Arnaud G L’huillier and others
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Pages 53–62, https://doi.org/10.1093/infdis/jiz471

This substudy of a randomized controlled trial shows that the high-dose influenza vaccine elicits significantly better T-cell responses than the standard-dose vaccine in organ transplant patients and provides evidence that it may be the preferred vaccine in the transplant setting.

VIRUSES

Liva Checkmahomed and others
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Pages 63–70, https://doi.org/10.1093/infdis/jiz418

The I38T PA substitution associated with baloxavir resistance did not alter the replication kinetics of A(H1N1)pdm09 and A(H3N2) viruses in vitro. Similarly, the wild-type and its I38T mutant induced similar weight loss with comparable lung titers in a mouse model.

Young Hyun Park and others
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Pages 71–80, https://doi.org/10.1093/infdis/jiz506

Genetic differences in ANP32A between chicken and humans and the differential effects of ANP32 family members on influenza virus replication could result in PB2-627 residue-dependent host restriction.

C Sarai Racey and others
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Pages 81–90, https://doi.org/10.1093/infdis/jiz422

A data linkage of the cervix screening program registry to the immunization registry in British Columbia showed that women vaccinated against HPV have a lower incidence of cervical dysplasia compared to unvaccinated women.

Julia L Finkelstein and others
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Pages 91–101, https://doi.org/10.1093/infdis/jiz427

In a nested case-control study, biomarkers of serum ferritin, vitamin A (RBP), and IL-15 are associated with apparent DENV infection, yet not with nonfebrile DENV, and may play a role in the immunopathology of dengue illness.

Benjamin Emmanuel and others
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Pages 102–109, https://doi.org/10.1093/infdis/jiz435

HIV/AIDS

Stéphane Isnard and others
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Pages 110–121, https://doi.org/10.1093/infdis/jiz423
Ana Godinho-Santos and others
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Pages 122–126, https://doi.org/10.1093/infdis/jiz431

Follicular helper T cells support productive HIV-2 infection and are preferential viral targets in HIV-2-infected individuals. This is particularly relevant given the slow rate of CD4 decline, reduced viremia, and high titers of neutralizing antibodies that characterize HIV-2-infected patients.

PARASITES

Hugh W F Kingston and others
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Pages 127–137, https://doi.org/10.1093/infdis/jiz359

Hypotension is a common feature of bacterial sepsis but infrequent in severe malaria. the level of cell-free hemoglobin, which scavenges the vasodilator nitric oxide, was increased during severe malaria and associated with higher blood pressure and vascular resistance but impaired peripheral perfusion.

Oumar Attaher and others
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Pages 138–145, https://doi.org/10.1093/infdis/jiz415

BACTERIA

Anthea L Katelaris and others
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Pages 146–155, https://doi.org/10.1093/infdis/jiz430

This analysis found BCG was associated with a lower prevalence of LTBI (measured via IGRA) in adults with recent exposure to active tuberculosis. These results suggest BCG may provide durable protection against Mycobacterium tuberculosis infection as well as disease.

PATHOGENESIS AND HOST RESPONSE

Bronwyn M Gunn and others
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Pages 156–161, https://doi.org/10.1093/infdis/jiz364

The humoral immune response in human survivors of Ebola virus disease includes the development of neutralizing antibodies and polyfunctional IgG1 and IgA antibodies that can mediate effector functions against the Ebola virus glycoprotein via multiple innate immune effector cell types.

Catherine Riou and others
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Pages 162–167, https://doi.org/10.1093/infdis/jiz417

ERRATA

The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Page 168, https://doi.org/10.1093/infdis/jiz350
Yun Lu and others
The Journal of Infectious Diseases, Volume 221, Issue 1, 1 January 2020, Page 168, https://doi.org/10.1093/infdis/jiz463
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close